Published in Eur J Health Econ on June 17, 2012
Feasibility and effectiveness of a low cost campaign on antibiotic prescribing in Italy: community level, controlled, non-randomised trial. BMJ (2013) 1.47
Tackling the threat of antimicrobial resistance: from policy to sustainable action. Philos Trans R Soc Lond B Biol Sci (2015) 1.00
Systematic Review of Factors Associated with Antibiotic Prescribing for Respiratory Tract Infections. Antimicrob Agents Chemother (2016) 0.76
Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis (2010) 3.65
Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med (2009) 2.70
Antimicrobial drug use and resistance in Europe. Emerg Infect Dis (2008) 2.68
Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis (2004) 2.35
The sale of antibiotics without prescription in pharmacies in Catalonia, Spain. Clin Infect Dis (2009) 2.29
National campaigns to improve antibiotic use. Eur J Clin Pharmacol (2006) 1.84
The use and resistance to antibiotics in the community. Int J Antimicrob Agents (2003) 1.77
Self-medication with antibiotics--does it really happen in Europe? Health Policy (2005) 1.67
Use of antimicrobial agents in consumer products. Arch Dermatol (2002) 1.59
Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. Emerg Infect Dis (2002) 1.57
European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach. Br J Clin Pharmacol (2004) 1.54
Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Health Policy (2005) 1.36
The macro determinants of health expenditure in the United States and Canada: assessing the impact of income, age distribution and time. Health Policy (2005) 1.28
Antibiotic prescription rates vary markedly between 13 European countries. Scand J Infect Dis (2002) 1.20
National cultural dimensions as drivers of inappropriate ambulatory care consumption of antibiotics in Europe and their relevance to awareness campaigns. J Antimicrob Chemother (2011) 1.18
Are cultural dimensions relevant for explaining cross-national differences in antibiotic use in Europe? BMC Health Serv Res (2008) 1.16
Antibiotic use following a Korean national policy to prohibit medication dispensing by physicians. Health Policy Plan (2005) 1.15
Polypharmacy in general practice: differences between practitioners. Br J Gen Pract (1999) 1.12
Antibiotics in the community: a typology of user behaviours. Patient Educ Couns (2008) 1.11
Socioeconomic determinants of outpatient antibiotic use in Europe. Int J Public Health (2010) 1.08
Antibiotic policies in Central Eastern Europe. Int J Antimicrob Agents (2004) 1.05
Intervention research to promote clinically effective and economically efficient use of pharmaceuticals: the International Network for Rational Use of Drugs. J Clin Epidemiol (1991) 1.02
Impact of the French campaign to reduce inappropriate ambulatory antibiotic use on the prescription and consultation rates for respiratory tract infections. J Antimicrob Chemother (2011) 0.97
Achievements of the Belgian Antibiotic Policy Coordination Committee (BAPCOC). Euro Surveill (2008) 0.92
An economic perspective on policy to reduce antimicrobial resistance. Soc Sci Med (1998) 0.89
Economic implications of antibiotic resistance in a global economy. J Health Econ (2002) 0.87
Small area variations and welfare loss in the use of outpatient antibiotics. Health Econ Policy Law (2009) 0.79
Influence of bacterial resistances on the efficiency of antibiotic treatments for community-acquired pneumonia. Eur J Health Econ (2007) 0.78
Quality incentives in a regulated market with imperfect information and switching costs: capitation in general practice. J Health Econ (2000) 0.94
Intravitreal and systemic foscarnet in the treatment of AIDS-related CMV retinitis. Eur J Ophthalmol (1996) 0.76
[Rupture of the splenic artery during pregnancy]. Minerva Ginecol (1978) 0.75
[Incidence and drug sensitivity of Pseudomonas aeruginosa recently isolated in the clinical complex of the Arcispedale di S. Maria Nuova and the Università degli Studi di Firenze]. G Ital Chemioter (1977) 0.75
Pulmonary hypertension associated with human immunodeficiency virus infection. Report of two cases and review of the literature. G Ital Cardiol (1998) 0.75